Navigation Links
DermTech Appoints BioStatistical Pioneer, John Quackenbush, Ph.D., as a Member of the Company's Scientific Advisory Board
Date:10/10/2007

LA JOLLA, Calif., Oct. 10 /PRNewswire/ -- DermTech International, Inc., a biotechnology company developing skin sampling technologies for the early detection of melanoma and other diseases, today appointed John Quackenbush, Ph.D. to the company's Scientific Advisory Board. Dr. Quackenbush is a Professor of Biostatistics and Computational Biology at the Dana-Farber Cancer Institute and Professor of Computational Biology and Bioinformatics at the Harvard School of Public Health. Since his 1992 receipt of a five-year fellowship from the National Center for Human Genome Research to study various aspects of genomics, Quackenbush has been widely recognized as a pioneer in the area of biological data management, analysis and interpretation.

"We are very pleased to welcome John to DermTech's SAB," said George Schwartz, the company's president and chief executive officer. "We are confident that his world-recognized expertise in bioinformatics, especially focused on class prediction algorithms for biomarker determination, will be a major asset as we accelerate the development of our EGIR-based assay for the early detection of melanoma." EGIR (Epidermal Genetic Information Retrieval) is DermTech's patented technology that uses noninvasive "tape-stripping" to identify the presence of disease. Other EGIR applications include drug development for products, such as anti-aging treatments and theranostics.

"I am looking forward to working with DermTech to help drive the development of what I expect will become a key new technique in the early detection of skin cancer and other diseases," said Quackenbush.

Dr. Quackenbush's work focuses on functional and comparative genomics and bioinformatics and their application to the study of human disease. Quackenbush is currently looking at patterns of gene expression in cancer, with the goal of elucidating the networks and pathways that are critical in the development and progression of the disease. He is also working on a large-scale project funded by an Oracle Challenge Grant aimed at creating a database that will link clinical and research data with other information available in the public domain.

About Dr. Quackenbush:

Dr. Quackenbush completed a Ph.D. in theoretical physics in 1990, followed by a two-year postdoctoral position in experimental particle physics and phenomenology. He has held positions at The Salk Institute, Stanford University and The Institute for Genomic Research (TIGR). He is on the editorial boards of five major journals and is a member of two National Research Council panels that are examining the applications of genomic approaches to the study of toxicology.

About DermTech:

Headquartered in La Jolla, California, DermTech International (http://www.dermtech.com) specializes in the development and validation of molecular tests using specimens derived from the skin. The company's proprietary Epidermal Genetic Information Retrieval (EGIR) technology is being studied in the context of tracking treatment efficacy for a variety of dermatologic and other conditions, including the effects of drugs on skin at the molecular level in advance of observable clinical results, and aiding in the diagnosis of disease. DermTech is actively pursuing research using EGIR and its applications toward molecular diagnostics and theranostics in the areas of melanoma, prostate cancer and various skin disorders, such as psoriasis. For additional information, visit http://www.dermtech.com

Contacts: DermTech

George Schwartz

858.450.4222

For DermTech

Jennifer Larson

415.409.2729

jlarson@labfive.com


'/>"/>
SOURCE DermTech International, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Sharon Ethanol appoints operations director
2. Kyron appoints former AMA chairman to board
3. Brady appoints GE efficiency expert as CTO
4. Merge Healthcare appoints new CEO, reports $215 million Q2 loss
5. Johnson Controls appoints Roell to head EOC
6. SecurePipe appoints two senior execs
7. Milwaukees PointOne appoints new president and CEO
8. Third Wave appoints new chairman
9. Midwest Venture Summit disappoints; Cato grades Midwest governors
10. Sonic Foundry appoints Engineering Dean and Cometa CEO to Board of Directors
11. TeraMEDICA Appoints Prekop as New President
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... 27, 2016   Ginkgo Bioworks , a leading ... was today awarded as one of the World ... world,s most innovative companies. Ginkgo Bioworks is engineering ... real world in the nutrition, health and consumer ... with customers including Fortune 500 companies to design ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... the release of its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” ... and retention in this eBook by providing practical tips, tools, and strategies for ...
(Date:6/23/2016)... 2016 Houston Methodist Willowbrook Hospital has ... Association to serve as their official health care ... Willowbrook will provide sponsorship support, athletic training services, ... coaches, volunteers, athletes and families. "We ... Association and to bring Houston Methodist quality services ...
(Date:6/23/2016)... ... 2016 , ... Supplyframe, the Industry Network for electronics hardware ... . Located in Pasadena, Calif., the Design Lab’s mission is to bring together ... built and brought to market. , The Design Lab is Supplyframe’s physical representation ...
Breaking Biology Technology:
(Date:4/19/2016)... 20, 2016 The new GEZE ... compact web-based "all-in-one" system solution for all door components. ... or the door interface with integration authorization management system, ... systems. The minimal dimensions of the access control and ... building installations offer considerable freedom of design with regard ...
(Date:4/14/2016)... 14, 2016 BioCatch ™, ... today announced the appointment of Eyal Goldwerger ... Goldwerger,s leadership appointment comes at a time ... the deployment of its platform at several of the ... which discerns unique cognitive and physiological factors, is a ...
(Date:3/31/2016)... -- Genomics firm Nabsys has completed a financial  restructuring under ... M.D., who returned to the company in October 2015. ... including Chief Technology Officer, John Oliver , Ph.D., ... Vice President of Software and Informatics, Michael Kaiser ... Bready served as CEO of Nabsys from 2005-2014 and ...
Breaking Biology News(10 mins):